Bryce Point Capital, LLC Natera, Inc. Transaction History
Bryce Point Capital, LLC
- $118 Billion
- Q2 2025
A detailed history of Bryce Point Capital, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Bryce Point Capital, LLC holds 4,017 shares of NTRA stock, worth $641,956. This represents 0.57% of its overall portfolio holdings.
Number of Shares
4,017
Previous 5,411
25.76%
Holding current value
$641,956
Previous $834 Million
18.66%
% of portfolio
0.57%
Previous 0.63%
Shares
3 transactions
Others Institutions Holding NTRA
# of Institutions
686Shares Held
126MCall Options Held
827KPut Options Held
1.14M-
Vanguard Group Inc Valley Forge, PA12.7MShares$2.03 Billion0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.5MShares$1.68 Billion0.18% of portfolio
-
Jpmorgan Chase & CO New York, NY7.36MShares$1.18 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.08 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.55MShares$727 Million3.7% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $15.5B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...